Blanca Herrero

ORCID: 0000-0002-8083-5280
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Childhood Cancer Survivors' Quality of Life
  • COVID-19 Clinical Research Studies
  • CAR-T cell therapy research
  • HER2/EGFR in Cancer Research
  • Respiratory viral infections research
  • Acute Lymphoblastic Leukemia research
  • Chronic Lymphocytic Leukemia Research
  • Respiratory Support and Mechanisms
  • Kawasaki Disease and Coronary Complications
  • Hematopoietic Stem Cell Transplantation
  • Breast Cancer Treatment Studies
  • SARS-CoV-2 and COVID-19 Research
  • Cancer Treatment and Pharmacology
  • Palliative Care and End-of-Life Issues
  • Neuroblastoma Research and Treatments
  • Biosimilars and Bioanalytical Methods
  • Advanced Breast Cancer Therapies
  • Neutropenia and Cancer Infections
  • Acute Myeloid Leukemia Research
  • Virus-based gene therapy research
  • Immunodeficiency and Autoimmune Disorders
  • Neonatal Health and Biochemistry
  • Urinary Tract Infections Management
  • Ethics in Clinical Research
  • Immune Cell Function and Interaction

Hospital Infantil Universitario Niño Jesús
2012-2025

Instituto de Investigación Biomédica de Salamanca
2021-2025

Centro de Investigación del Cáncer
2021-2025

Universidad de Salamanca
2021-2025

Hospital Universitario de La Princesa
2024

Hospital General Universitario Gregorio Marañón
2020-2024

GEICAM – Spanish Breast Cancer Group
2024

Centro de Investigación Biomédica en Red de Cáncer
2021

Hospital Universitario Infanta Leonor
2021

Hospital del Niño
2013-2021

Cinta Moraleda Miquel Serna‐Pascual Antoni Soriano‐Arandes Silvia Simó Nebot Cristina Epalza and 87 more Mar Santos Carlos Grasa María José Sanjinés Rodríguez Beatriz Soto Nerea Gallego Yolanda Ruíz María Urretavizcaya-Martínez Marta Pareja Francisco José Sanz-Santaeufemia Victòria Fumadó Miguel Lanaspa Iolanda Jordán Luis Prieto Sylvia Belda Hofheinz Belén Toral-Vázquez Elena Rincón Nuria Gil-Villanueva Ana Méndez‐Echevarría Ana Castillo-Serrano Jacques G. Rivière Pere Soler‐Palacín Pablo Rojo Alfredo Tagarro Rut del Valle Ana Barrios Sara Villanueva Jesús Ruíz-Contreras Lourdes Gutiérrez Cristina Calvo Paula Rodríguez Molino María José Mellado María de Ceano María Penín Serena Villaverde María José de Dios Pérez Enrique Otheo Lola Falcón-Neyra Olaf Neth Peter Olbrich Walter Goycoechea Laura Martín María Iglesias José Antonio Alonso‐Cadenas Blanca Herrero Elvira Cobo Mariam Tovizi Pilar Galán del Río Sara Guillén Adriana Navas María Luz García‐García Marta Llorente Sara Pérez Lucía Figueroa Amanda Bermejo P Mendoza Gema Sabrido María José Hernández Ana Belén Jiménez Arantxa Berzosa Marta Illán Ramos Maria de Lourdes Amaral Bernardino Julia Jensen Paula Vidal Sara Domínguez‐Rodríguez Lourdes Gutiérrez Angustias Ocaña I. Belinchón María Fernanda Guzmán María‐Jesús Pascual Ana López Machín Beatriz Ruiz Ana Ruiz María José Méndez Ángela María Rincón Hurtado Fátima Ara Fernando Cabañas Manuel Oltra Álvaro Villarroya María Isabel Sánchez-Códez Elena Montesinos Mercedes Aguirre Neus Rius Alba Gómez Rafael Bretón Margarita Rodríguez-Benjumea Ana Sara Martins de Campos Mercedes García Reymundo

Abstract Some clusters of children with a multisystem inflammatory syndrome (MIS-C) associated severe acute respiratory coronavirus 2 (SARS-CoV-2) infection have been reported. We describe the epidemiological and clinical features MIS-C in Spain. is potentially condition that presents recent SARS-CoV-2 infection.

10.1093/cid/ciaa1042 article EN other-oa Clinical Infectious Diseases 2020-07-22
Serena Villaverde Sara Domínguez‐Rodríguez Gema Sabrido Conchita Pérez-Jorge M. Gutiérrez Plata and 95 more María Pilar Romero‐Gómez Carlos Grasa Ana Belén Jiménez Elena de las Heras Antonio Broncano María del Mar Núñez Marta Illán Ramos Paloma Merino Beatriz Soto David M. Arana Amanda Bermejo P Mendoza Manuel Gijón Begoña Pérez‐Moneo Cinta Moraleda Alfredo Tagarro Cristina Calvo Ma José Mellado Paula Rodríguez-Molino Teresa del Rosal Mar Santos Marisa Navarro Elena Rincón Begoña Santiago Jesús Saavedra‐Lozano David Aguilera‐Alonso Cristina Epalza Daniel Blázquez‐Gamero Sara Villanueva Pablo Rojo Gero Calleja J. A. Alonso Mercedes de la Torre Francisco José Sanz-Santaeufemia María Iglesias Blanca Herrero María del Mar Alonso Antoni Soriano‐Arandes J.M. Pujol Susana Melendo Pere Soler‐Palacín Silvia Simó Nebot Victòria Fumadó Miguel Lanaspa Mikel Urretavizcaya Mercedes Herranz Marta Pareja Fátima Ara Santiago Cabañas Rut del Valle Ana Barrios Enrique Otheo J. Vázquez Lola Falcón-Neyra Olaf Neth Peter Olbrich Walter Goicoechea Laura Martín Lucía Figueroa María Teresa Pozo Llorente María Penín Claudia García María de los Ángeles García Teresa Alvaredo Ma Inmaculada Olmedo Agustín López Elvira Cobo Mariam Tovizi Pilar Galán del Río Sara Guillén Adriana Navas María Luz García‐García Sara Pérez María José Hernández Arantxa Berzosa Nerea Gallego Ana López Beatriz Ruiz Santiago Alfayate Ana Ruiz Eloísa Cervantes Maria José González Ángela María Rincón Hurtado Yolanda Ruíz Cristina García Inés Amich Manuel Oltra Álvaro Villaroya Angustias Ocaña I. Belinchón María Fernanda Guzmán María‐Jesús Pascual María Isabel Sánchez-Códez Elena Montesinos Julia Jensen

10.1016/j.jpeds.2021.01.027 article EN other-oa The Journal of Pediatrics 2021-01-21

Celiac disease (CD) is a common disorder in children and adults. However, limited data are available when comparing differences between both populations.To prospectively evaluate compare the clinical histological features present at diagnosis cohort of celiac adults.Consecutive new cases diagnosed 2000 2006 were included (66 54 adults). The spectrum was categorized two groups: (a) typical (malabsorption, chronic diarrhea, or failure to thrive) (b) oligosymptomatic (abdominal pain, anemia,...

10.1111/j.1572-0241.2008.01977.x article EN The American Journal of Gastroenterology 2008-08-12

AIM:To evaluate the predictive value of tissue transglutaminase (tTG) antibodies for villous atrophy in adult and pediatric populations to determine if duodenal biopsy can be avoided.

10.3748/wjg.15.4775 article EN cc-by-nc World Journal of Gastroenterology 2009-01-01

Introduction Loss of B-cell aplasia (BCA) is a well-known marker functional loss CD19 CAR-T. Most relapses and BCA occur in the first months after CAR-T infusion. In addition, high tumor burden (HTB) has shown to have strong impact on relapse, especially CD19-negative. However, little known about late or relationship between pre-infusion patients infused with tisagenlecleucel for relapsed/refractory acute lymphoblastic leukemia. Therefore, optimal management yet be defined. Methods We...

10.3389/fimmu.2023.1280580 article EN cc-by Frontiers in Immunology 2024-01-16

We aimed to identify the spectrum of disease in children with COVID-19, and risk factors for admission paediatric intensive care units (PICUs). conducted a multicentre, prospective study SARS-CoV-2 infection 76 Spanish hospitals. included COVID-19 or multi-inflammatory syndrome (MIS-C) younger than 18 years old, attended during first year pandemic. enrolled 1200 children. A total 666 (55.5%) were hospitalised, 123 (18.4%) required PICU. Most frequent major clinical syndromes cohort mild...

10.1007/s00431-021-04306-6 article EN other-oa European Journal of Pediatrics 2021-11-05

Triple-negative breast cancer (TNBC) is highly responsive to neoadjuvant polychemotherapy regimens including anthracyclines, taxanes, and, more recently, carboplatin. However, there inadequate information on the individual contribution of each these agents global activity combinations, and use combinations up four drugs associated with relevant toxicity. Identifying single-drug in clinical setting challenging. We developed patient-derived xenografts (PDXs) from several chemotherapy-naïve...

10.1038/s41598-021-85962-4 article EN cc-by Scientific Reports 2021-03-29

We aimed to identify risk factors causing critical disease in hospitalized children with COVID-19 and build a predictive model anticipate the probability of need for care.We conducted multicenter, prospective study SARS-CoV-2 infection 52 Spanish hospitals. The primary outcome was care. used multivariable Bayesian estimate needing care.The enrolled 350 from March 12, 2020, July 1, 2020: 292 (83.4%) 214 (73.7%) were considered have relevant COVID-19, whom 24.2% required Four major clinical...

10.1097/inf.0000000000003204 article EN The Pediatric Infectious Disease Journal 2021-07-12

Despite the increasing number of central nervous system (CNS) tumour survivors, long-term (LT) sequelae remain a substantial burden on their health through various life stages. The aim our study was to evaluate late morbidity, health-related quality (HRQoL), self-esteem, functional status, adaptive behaviour, physical activity and social outcomes such as education, employment, relationship status possession driver's license, in addition role LT effects radiotherapy (RTx) these outcomes....

10.1016/j.anpede.2024.503719 article EN cc-by-nc-nd Anales de Pediatría (English Edition) 2025-01-01

Background/Objectives: Despite the current international prognostic index for chronic lymphocytic leukemia (CLL) being widely accepted and broadly used, it does not consider kinetics of B-cell clone over time. Here, we investigated potential association between distinct features leukemic cells other immune in blood clonal B-cells CLL stage Binet A/Rai 0 (A/0) patients; Methods: Based on cell kinetics, 69 A/0 cases followed a median 105 months were classified as carrying stable (n = 53) vs....

10.3390/cancers17030347 article EN Cancers 2025-01-21

To characterize the clinical phenotypes of SARS-CoV-2 infection in hospitalized children as part EPICO multicenter cohort study. We included with confirmed from Colombian and Spanish institutions to assess disease evolution outcomes. Cluster analysis was performed identify phenotypes. A total 2318 patients were (55% male, 36% infants). Five phenotype clusters emerged: 1 (26.5%): infants without comorbidities, low PICU admissions mortality; 2 (18.5%): respiratory high microorganism...

10.3389/ijph.2025.1607246 article EN cc-by International Journal of Public Health 2025-03-18

Background/Objectives: Immune effector cell-associated hematotoxicity (ICAHT) is a frequent adverse event after chimeric antigen receptor (CAR)-T cell therapy. Grade ≥ 3 thrombocytopenia occurs in around one-third of patients, and many them become platelet transfusion-dependent. Eltrombopag thrombopoietin agonist (TPO-RA) able to accelerate megakaryopoiesis, which has been used successfully patients with bone marrow failure immune (ITP). Its role managing other cytopenias CAR-T cell-treated...

10.3390/jcm13175117 article EN Journal of Clinical Medicine 2024-08-28

ObjectivesTo determine the time to reverse transcription-polymerase chain reaction (RT-PCR) negativity after first positive RT-PCR test, factors associated with longer negativity, proportion of children seroconverting proven severe acute respiratory syndrome coronavirus 2 infection, and lack seroconversion.Study designThe Epidemiological Study Coronavirus in Children Spanish Society Pediatrics is a multicenter study conducted assess characteristics disease 2019. In subset patients, 3 serial...

10.1016/j.jpeds.2021.09.029 article EN other-oa The Journal of Pediatrics 2021-09-27

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established treatment for high-risk hematological malignancies in the pediatric population, but relapse remains leading cause of death. We analyzed risk factors associated with relapse.Data from 353 allo-HSCTs 1989 to 2015 our center were studied retrospectively. performed a multivariate analysis pre- and postransplantation variables developed predictive score using significant this training cohort. The results confirmed...

10.1016/j.bbmt.2018.08.012 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2018-08-22

Abstract In this cohort of 42 adolescents with a previous multisystem inflammatory syndrome (MIS-C) diagnosis, 32 (76.2%) were vaccinated COVID-19 vaccines, low incidence relevant adverse events. More importantly, no new MIS-C or myocarditis occurred after median 10 weeks (range 5.3-19.7) post-vaccination.

10.1093/jpids/piac076 article EN Journal of the Pediatric Infectious Diseases Society 2022-07-29

Hemophagocytic lymphohistiocytosis (HLH) is a condition caused by pathologic immune activation, which responsible for its signs and symptoms. It may also appear as secondary process malignancy. Developing HLH during treatment acute lymphoblastic leukemia (ALL) extremely uncommon, but underdiagnosis be fatal. Two patients with ALL on chemotherapy maintenance who developed triggered infection are presented here. We emphasize the importance of being aware this when patient in complete remission...

10.1097/mph.0000000000000932 article EN Journal of Pediatric Hematology/Oncology 2017-08-30

Pneumonia is a frequent manifestation of coronavirus disease 2019 (COVID-19) in hospitalized children.The study involved 80 hospitals the severe acute respiratory syndrome 2 (SARS-CoV-2) Spanish Pediatric National Cohort. Participants were children <18 years, with SARS-CoV-2 community-acquired pneumonia (CAP). We compared clinical and radiological characteristics SARS-CoV-2-associated CAP due to other viral etiologies from ValsDance (retrospective) cohort.In total, 151 138 included. Main...

10.1002/ppul.26042 article EN Pediatric Pulmonology 2022-06-27
Coming Soon ...